Esta información es solo con fines educativos. No constituye consejo médico. Consulte siempre a un profesional de salud cualificado.
Descripción, Dosificación, Efectos secundarios, Contraindicaciones. Data from EMA, URPL, openFDA and other regulatory sources.
| Sertraline | Escitalopram | |
|---|---|---|
| Sustancias activas | SERTRALINE HYDROCHLORIDE | ESCITALOPRAM (ESCITALOPRAM OXALATE) |
| Código ATC | N06AB06 | N06AB10 |
| Forma | TABLET, FILM COATED | — |
| Dosificación | 50 mg/1 | — |
| Vía de administración | ORAL | — |
| Fabricante | Exelan Pharmaceuticals, Inc. | JUBILANT GENERICS LIMITED |
Sertraline (INN: SERTRALINE HYDROCHLORIDE, ATC N06AB06) and Escitalopram (INN: ESCITALOPRAM (ESCITALOPRAM OXALATE), ATC N06AB10) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Esta información es solo con fines educativos. No constituye consejo médico. Consulte siempre a un profesional de salud cualificado.